RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients
Clinical trial NCT07056478 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07056478
- Sponsor
- Prince of Wales Hospital, Shatin, Hong Kong
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2028-01-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.